Can almonds tame overnight blood sugar in pregnancy?
NCT ID NCT07069855
First seen Sep 15, 2026 · Last updated Sep 16, 2026 · Updated 1 time
Summary
This trial tests whether eating almonds as an evening snack improves overnight blood sugar in pregnant women with gestational diabetes. About 156 women will either eat 43 grams of whole almonds daily or a nut-free snack for 28 days. Researchers will measure blood sugar levels overnight and during the day to see if almonds make a difference.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- almonds eaten as an evening snack
- What this could lead to
- If almonds help, this could offer a simple dietary way to improve overnight blood sugar for pregnant women with gestational diabetes.
- What could go wrong
- This is a small dietary study, and snack changes may not be enough to control blood sugar. Results may not apply to all pregnant women or replace standard care.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 156 people
The number the study aims to enrol. It can still change while the study runs.
- Expected to start
-
Dec 2026
An estimate. Start dates often move.
- Expected to finish
-
Dec 2027
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
16 to 55 years
- Sex
-
Female participants only
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: 1. Age over 16 years 2. Singleton pregnancy 3. 25 to 31+6 weeks' gestation diagnosed with GDM using a standard clinical 75g oral glucose tolerance test (OGTT), as per the guidelines of the National Institute of Health and Care Excellence (NICE), and had their first post-diagnosis consultation (approx. 7-10 days later). The NICE criteria state that the diagnosis of GDM will be made with one or more glucose concentrations during the OGTT of \>5.6 mmol/l in the fasting state; \>7.8 mmol/l 2 hours after 75g glucose 4. Planned antenatal care at the same centre 5. GDm-Health (a digital app for the management of diabetes in pregnancy) used as part of their management for GDM 6. Willing and able to give informed consent Exclusion Criteria: 1. Age under 16 years or over 55 years 2. Multiple pregnancy 3. Non-snack consumers 4. Smokers 5. Women who would work night shifts over the study period 6. Women who have already commenced insulin for the treatment of GDM 7. Allergy or intolerance to nuts 8. Pre-existing medical conditions, including Type 1 or Type 2 diabetes, chronic coronary, renal or bowel disease or history of cholestatic liver disease or pancreatitis. Presence of gastrointestinal disorder or use of a drug which is likely to alter gastrointestinal motility or nutrient absorption, previous bariatric surgery 9. Unwilling or unable to give informed consent
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Gestational diabetes are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a social media platform help manage gestational diabetes?
- Chatbot coach takes aim at diabetes risk after pregnancy
- Wearable sensors in early pregnancy may reveal hidden diabetes risk
- Could a simple blood test predict newborn risks in diabetic pregnancies?
- Wearable sensor may replace the dreaded glucose drink test for gestational diabetes
- Wearable tech could stop Post-Pregnancy diabetes in its tracks